Eagle Pharmaceuticals, Inc. (25) | License Agreements (3)
Recent Contracts
-
License Agreement, dated as of August 6, 2021, between the Registrant and AOP Orphan Pharmaceuticals GmbH
(Filed With SEC on November 9, 2021)
-
License Agreement, dated as of August 19, 2021, between the Registrant and Combioxin SA
(Filed With SEC on November 9, 2021)
-
Fourth Amendment to the Exclusive License Agreement, dated April 12, 2019, by and between Eagle Pharmaceuticals, Inc., a Delaware corporation and Teva Pharmaceuticals...
(Filed With SEC on May 7, 2019)